BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9231817)

  • 1. Role for endothelin-1 in angiotensin II-mediated hypertension.
    Rajagopalan S; Laursen JB; Borthayre A; Kurz S; Keiser J; Haleen S; Giaid A; Harrison DG
    Hypertension; 1997 Jul; 30(1 Pt 1):29-34. PubMed ID: 9231817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function.
    d'Uscio LV; Shaw S; Barton M; Lüscher TF
    Hypertension; 1998 Jun; 31(6):1305-10. PubMed ID: 9622146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
    Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
    Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats.
    Touyz RM; Fareh J; Thibault G; Schiffrin EL
    Hypertension; 1996 Nov; 28(5):797-805. PubMed ID: 8901826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    Gorbea-Oppliger VJ; Fink GD
    J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms.
    Rossi GP; Sacchetto A; Rizzoni D; Bova S; Porteri E; Mazzocchi G; Belloni AS; Bahcelioglu M; Nussdorfer GG; Pessina AC
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):949-56. PubMed ID: 10764658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency.
    Li Q; Dale WE; Hasser EM; Blaine EH
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R200-7. PubMed ID: 8760221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.
    Yao L; Kobori H; Rahman M; Seth DM; Shokoji T; Fan Y; Zhang GX; Kimura S; Abe Y; Nishiyama A
    Hypertens Res; 2004 Jul; 27(7):493-500. PubMed ID: 15302986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1.
    Ballew JR; Watts SW; Fink GD
    J Pharmacol Exp Ther; 2001 Feb; 296(2):345-50. PubMed ID: 11160616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
    Hara K; Kobayashi N; Nakano S; Mori Y; Tsubokou Y; Matsuoka H
    Hypertens Res; 2001 Jan; 24(1):55-64. PubMed ID: 11213031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor.
    Lin YJ; Kwok CF; Juan CC; Hsu YP; Shih KC; Chen CC; Ho LT
    Biochem Biophys Res Commun; 2014 Aug; 451(2):263-9. PubMed ID: 25088996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta.
    Ishizaka N; de León H; Laursen JB; Fukui T; Wilcox JN; De Keulenaer G; Griendling KK; Alexander RW
    Circulation; 1997 Sep; 96(6):1923-9. PubMed ID: 9323082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.
    Kowala MC; Murugesan N; Tellew J; Carlson K; Monshizadegan H; Ryan C; Gu Z; Kane B; Fadnis L; Baska RA; Beyer S; Arthur S; Dickinson K; Zhang D; Perrone M; Ferrer P; Giancarli M; Baumann J; Bird E; Panchal B; Yang Y; Trippodo N; Barrish J; Macor JE
    J Pharmacol Exp Ther; 2004 Apr; 309(1):275-84. PubMed ID: 14718594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
    Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
    Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.
    Seccia TM; Belloni AS; Kreutz R; Paul M; Nussdorfer GG; Pessina AC; Rossi GP
    J Am Coll Cardiol; 2003 Feb; 41(4):666-73. PubMed ID: 12598081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells.
    Ishizaka N; Griendling KK
    Hypertension; 1997 Mar; 29(3):790-5. PubMed ID: 9052897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.